Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Celgene Corp (NQ: CELG)
124.91 USD  +1.43 (+1.16%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 124.56
Bid (Size) 124.87 (300)
Ask (Size) 124.91 (100)
Prev. Close 123.48
Today's Range 120.35 - 125.05
52wk Range 58.53 - 131.41
Shares Outstanding N/A
Dividend Yield N/A
Featured News
More News
Why I stopped using stop loss orders
May 09, 2013
A big problem with stop losses is that you give up control of your sell order. During volatile markets, that can cost you money. But there is an alternative, writes Michael Sincere. Read More
category VRX , Opinion , Commentary , and 12 more.
from MarketWatch
Minyanville's T3 Morning Market Call: Time to Take Profits or Stay the Course?
May 06, 2013
Banks have been a bit lethargic while tech continues to be filled with opportunity. Read More
category MSFT , CELG , NFLX , and 1 more.
from Minyanville Headlines

Featured News
Read More
A DeMark Look at IBB, XOP, and Some of Their Components
April 08, 2013
category GPOR , CELG , AMGN
from Minyanville Headlines
Stock Upgrades: Fast Money Makes a Run on JPMorgan Chase
April 05, 2013
category CELG , JPM , HBC
from Minyanville Headlines
Celgene Corporation Bulls Predict New Near-Term Highs
February 28, 2013
category CELG
from Minyanville Headlines
Six Things to Watch at Biotech CEO Conference
February 11, 2013
from Minyanville Headlines
Monday’s biggest gaining and declining stocks
February 11, 2013
category S , NKE , Financial Services , and 20 more.
from MarketWatch
Celgene Gets OK to Sell Blood Cancer Drug
February 11, 2013
from Minyanville Headlines
More News
Read More
Options Players Wage on Celgene Corporation
May 16, 2013
from AVAFIN
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter
May 15, 2013
category Benzinga , Highest EPS Estimates , CELG , and 6 more.
from Latest Articles from Benzinga.com
Jim Cramer's 5 Investing Sweet Spots
May 14, 2013
category Regeneron Pharmaceuticals Inc , EOG Resources Inc , ENSCO International Incorporated , and 14 more.
from CNBC.com News
Gene Therapy Company Bluebirdbio (BLUE) Files $86M IPO
May 14, 2013
from StreetInsider.com News Articles
Critical Alerts For Yahoo!, Celgene, Brinker International, Qlik Technologies, and Beam Released By InvestorsObserver
May 13, 2013
from PR Newswire
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Strategy Behind Our Success, We Get in Early: MDLZ, YHOO, F and CELG
May 11, 2013
from Marketwired News Releases
Acceleron’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes
May 10, 2013
from Business Wire News Releases
S&P Highlights Biotech ETFs
May 10, 2013
category Benzinga , ETFs , PJP , and 22 more.
from Latest Articles from Benzinga.com
NeoStem CEO's Letter to Shareholders
May 09, 2013
from GlobeNewswire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
2
The Tesla Model S Is the New Toyota Prius
Michael Comeau
3
The Top 5 Spookiest Technologies
Nick Shchetko
4
Black Swan Watch: Mexico's Super Volcano Could Be the Next Market Catalyst
Duncan Parker
5
The 50 Most Volatile Stocks of the S&P 1500
Bespoke Investment Group

Financial Product Guide